[Duchenne muscular dystrophy: Case of atypical presentation and early diagnosis]

Pablo Cabezudo García1, Esther Moreno Medinilla2, Rocío Calvo Medina2

  • 1Unidad de Neurociencias, Hospital Clínico Universitario Virgen de la Victoria.

Abstract

Insights

A rare genetic mutation caused Duchenne muscular dystrophy in an infant, despite initial negative genetic tests. Muscle biopsy revealed dystrophin absence, leading to the discovery of a novel mutation, highlighting the importance of comprehensive diagnostics for muscular dystrophy.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Duchenne muscular dystrophy (DMD) is a common, X-linked recessive disorder affecting 1 in 3300 male births.
  • While often hereditary, sporadic cases occur, with diagnosis typically around 4.83 years, though earlier detection is possible.
  • Early identification of DMD is crucial for timely management and intervention.

Observation:

  • An 18-month-old infant presented with failure to thrive, malnutrition, and respiratory issues.
  • Clinical findings included hypotonia and elevated creatine kinase, suggesting myopathy.
  • Initial genetic testing for DMD was negative.

Findings:

  • Muscle biopsy revealed a complete absence of dystrophin.
  • A subsequent, more sensitive genetic analysis identified a previously undescribed mutation.
  • This highlights limitations in standard genetic screening for DMD.

Implications:

  • Advanced genetic analysis is vital for diagnosing atypical DMD cases.
  • Identifying novel mutations expands our understanding of DMD genetics.
  • This case underscores the importance of correlating clinical, biochemical, and pathological findings for accurate diagnosis.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
114